MAXN vs. AIP, VLN, TGAN, CAN, MX, QUIK, AXTI, GCTS, MRAM, and ATOM
Should you be buying Maxeon Solar Technologies stock or one of its competitors? The main competitors of Maxeon Solar Technologies include Arteris (AIP), Valens Semiconductor (VLN), Transphorm (TGAN), Canaan (CAN), Magnachip Semiconductor (MX), QuickLogic (QUIK), AXT (AXTI), GCT Semiconductor (GCTS), Everspin Technologies (MRAM), and Atomera (ATOM). These companies are all part of the "semiconductors & related devices" industry.
Arteris (NASDAQ:AIP) and Maxeon Solar Technologies (NASDAQ:MAXN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.
In the previous week, Arteris had 4 more articles in the media than Maxeon Solar Technologies. MarketBeat recorded 8 mentions for Arteris and 4 mentions for Maxeon Solar Technologies. Maxeon Solar Technologies' average media sentiment score of 0.29 beat Arteris' score of -0.38 indicating that Arteris is being referred to more favorably in the media.
Maxeon Solar Technologies has a net margin of -37.92% compared to Maxeon Solar Technologies' net margin of -69.70%. Maxeon Solar Technologies' return on equity of -198.35% beat Arteris' return on equity.
Maxeon Solar Technologies received 19 more outperform votes than Arteris when rated by MarketBeat users. However, 57.69% of users gave Arteris an outperform vote while only 37.36% of users gave Maxeon Solar Technologies an outperform vote.
Arteris has higher earnings, but lower revenue than Maxeon Solar Technologies. Arteris is trading at a lower price-to-earnings ratio than Maxeon Solar Technologies, indicating that it is currently the more affordable of the two stocks.
Arteris currently has a consensus price target of $13.40, suggesting a potential upside of 71.36%. Maxeon Solar Technologies has a consensus price target of $4.41, suggesting a potential upside of 191.80%. Given Arteris' higher probable upside, analysts plainly believe Maxeon Solar Technologies is more favorable than Arteris.
64.4% of Arteris shares are owned by institutional investors. Comparatively, 47.7% of Maxeon Solar Technologies shares are owned by institutional investors. 33.7% of Arteris shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Arteris has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Maxeon Solar Technologies has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500.
Summary
Arteris beats Maxeon Solar Technologies on 11 of the 18 factors compared between the two stocks.
Get Maxeon Solar Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MAXN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MAXN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Maxeon Solar Technologies Competitors List
Related Companies and Tools
